LBBW Aktienanleihe VAR 26.07.2024/ DE000LB4CU16 /
18/06/2024 13:43:37 | Var.+2.000 | Denaro15:10:15 | Lettera- | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
84.720EUR | +2.42% | - Quantità in denaro: - |
- Quantità in lettera: - |
VARTA AG O.N. | 9.00 - | 26/07/2024 | Call |
GlobeNewswire
22:30
Trump Media & Technology Group Corp. Announces SEC Effectiveness of Amended Form S-1
GlobeNewswire
22:30
Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit
GlobeNewswire
22:30
Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Comb...
GlobeNewswire
22:30
EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneu...
GlobeNewswire
22:15
Kite Realty Group Trust to Report Second Quarter 2024 Financial Results on July 30, 2024
GlobeNewswire
22:12
FSLY Investor Alert: Securities Fraud Class Action Lawsuit Was Filed Against Fastly, Inc. Investors ...
GlobeNewswire
22:10
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
22:08
Brookfield Infrastructure Corporation Announces Results of Annual Meeting of Shareholders
GlobeNewswire
22:08
SPT Investors Alert: Securities Fraud Class Action Lawsuit Was Filed Against Sprout Social, Inc. (SP...
GlobeNewswire
22:08
LifeSave Kansas Now Carries Life-Saving Whole Blood Onboard All Transports Across the State
GlobeNewswire
22:05
Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology
GlobeNewswire
22:05
Euroseas Ltd. Announces Time Charter Contract for its third Fuel Efficient 1,800 teu Feeder Containe...
GlobeNewswire
22:05
Neurona Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for NR...